Valuation: Stereotaxis Inc

Market Cap 175M 153M 141M 131M 248M 16.66B 252M 1.69B 656M 8.19B 657M 643M 28.22B P/E 2026 *
-8.95x
P/E 2027 * -11.9x
Enterprise Value 175M 153M 141M 131M 248M 16.66B 252M 1.69B 656M 8.19B 657M 643M 28.22B EV / Sales 2026 *
4.44x
EV / Sales 2027 * 3.28x
Free-Float
84.63%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 03/02/2017
Director of Finance/CFO 57 01/10/2019
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 79 01/02/2005
Chairman - 03/02/2017
Director/Board Member 71 29/09/2016
Change 5-day change 1-year change 3-year change Capi.($)
-7.43%-2.84% - - 175M
+1.97%+2.03%+21.92%+0.83% 195B
+5.87%+5.27%-21.76%+26.78% 151B
+2.17%+0.89%-2.59%-16.42% 140B
+4.83%+2.06%-56.73%-15.69% 67.09B
+2.59%+3.95%+22.89%+3.15% 54.34B
+0.03%+2.19%-25.17%-31.30% 44.63B
+0.31%+1.30%+8.30%+43.25% 37.24B
-2.02%-3.91%+7.67%+9.53% 36.91B
+4.24%+4.66%-18.42%-2.34% 30.24B
Average +1.26%+2.74%-7.10%+1.98% 83.99B
Weighted average by Cap. +2.78%+3.44%-4.01%+2.00%

Financials

2026 *2027 *
Net sales 39.4M 34.44M 31.65M 29.5M 55.96M 3.75B 56.81M 380M 148M 1.84B 148M 145M 6.35B 53.28M 46.57M 42.8M 39.89M 75.67M 5.07B 76.82M 514M 200M 2.49B 200M 196M 8.59B
Net income -19.4M -16.96M -15.59M -14.53M -27.55M -1.85B -27.97M -187M -72.74M -908M -72.82M -71.26M -3.13B -13.62M -11.91M -10.95M -10.2M -19.35M -1.3B -19.65M -131M -51.09M -638M -51.14M -50.04M -2.2B
Net Debt - -
Logo Stereotaxis Inc
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-